{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:48Z","timestamp":1791357228485,"version":"4.3.1"},"reference-count":88,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p><jats:bold>Objectives:\u00a0<\/jats:bold> Antipsychotics have been widely used in the treatment of bipolar mania. The purpose of this manuscript was to briefly review the evidence of typical and atypical antipsychotics for the treatment of bipolar mania.<\/jats:p><jats:p><jats:bold>Methods:\u00a0<\/jats:bold> A detailed literature review was conducted on the use of typical and atypical antipsychotics in the treatment of bipolar mania using standard search engines. A summary of the published literature on each agent is described followed by a discussion on the overall comparison of the different agents.<\/jats:p><jats:p><jats:bold>Results:\u00a0<\/jats:bold> For typical antipsychotics, up until recently, there was a paucity of published evidence on their strengths and limitations in the treatment of bipolar mania. Recent studies have demonstrated clear evidence on the efficacy of haloperidol on the treatment of acute mania. The literature suggests a faster onset of action of haloperidol as compared to either lithium or atypical antipsychotics. A limitation of typical antipsychotics however, is the risk of tardive dyskinesia, extrapyramidal side effects and a possible increased risk of non\u2010adherence. Evidence on the efficacy for atypical antipsychotics has been demonstrated for aripiprazole, clozapine, olanzapine, quetiapine, risperidone and ziprasidone. Limitations as regards the use of atypical antipsychotics include the risk of weight gain and dyslipidemia. Comparison among different atypical antipsychotics agents are difficult to determine as there are no conclusive head to head studies. There is also a paucity of studies comparing atypical antipsychotics with lithium.<\/jats:p><jats:p><jats:bold>Conclusions:\u00a0<\/jats:bold> Evidence exists on the efficacy of both typical and atypical antipsychotics on the treatment of acute mania such that they are now clearly first\u2010line along with lithium. An important limitation of the published literature is that most of the studies were designed to obtain regulatory approval for the different agents therefore the generalizability of the findings to clinical practice remains unclear.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2009.00710.x","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T15:16:04Z","timestamp":1243869364000},"page":"45-54","source":"Crossref","is-referenced-by-count":47,"title":["Antipsychotic agents in the treatment of bipolar mania"],"prefix":"10.1111","volume":"11","author":[{"given":"Mauricio","family":"Tohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"299","volume-title":"Mood Disorders Across the Life Span","author":"Baldessarini RJ","year":"1996"},{"key":"e_1_2_7_3_2","first-page":"112","article-title":"Utilization therapeutique psychiatrique d\u2019une phenothiazine d\u2019action cetrale elective (4560RP)","volume":"110","author":"Delay J","year":"1952","journal-title":"Ann Med Psychol"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.10.1409"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700042021"},{"issue":"1","key":"e_1_2_7_6_2","first-page":"38","article-title":"Antipsychotic agents and bipolar disorder","volume":"59","author":"Tohen M","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-19920201-13"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750200050011"},{"issue":"1","key":"e_1_2_7_9_2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"151","author":"Hirschfeld RM","year":"1994","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00162-2"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(80)90029-4"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1981.tb00797.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1975.01760190036004"},{"key":"e_1_2_7_14_2","first-page":"33","article-title":"A comparison of thiothixene with chlorpromazine in the treatment of mania","volume":"8","author":"Janicak PG","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.169"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1967.01730190120016"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.06.003"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.02.006"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.12.1218"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00012"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.235"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07101560"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199703000-00006"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800250095013"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.165.1.113"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.11.1455"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290040069010"},{"issue":"11","key":"e_1_2_7_29_2","first-page":"12","article-title":"The role of neuroleptics in manic\u2010depressive illness","volume":"49","author":"Kane JM","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0116"},{"key":"e_1_2_7_31_2","first-page":"411","article-title":"Clozapine in severe mood disorders","volume":"56","author":"Zarate CA","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_32_2","first-page":"108","article-title":"Is clozapine a mood stabilizer?","volume":"56","author":"Zarate CA","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_33_2","first-page":"295","article-title":"Clozapine therapy in refractory affective disorders; polarity predicts response in long\u2010term follow\u2010up","volume":"55","author":"Banov MD","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_34_2","first-page":"411","article-title":"Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia","volume":"52","author":"McElroy SL","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90108-C"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.6.759"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.982"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418060-00007"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106059693"},{"key":"e_1_2_7_41_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1210"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1113"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2007.04.020"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.1.62"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.041301"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X46340"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2004.00115.x"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328080ca57"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0116"},{"key":"e_1_2_7_54_2","first-page":"249","article-title":"Risperidone in the treatment of mania","volume":"57","author":"Tohen M","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1057"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.229"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.2.141"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169068.34322.70"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108099418"},{"key":"e_1_2_7_61_2","unstructured":"WeislerR DunnJ EnglishP.Ziprasidone in adjunctive treatment of acute bipolar mania: randomized double\u2010blind placebo\u2010controlled trial.16th European College of Neuropsychopharmacology Congress Prague Czech Republic 20\u201324 September.2003."},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(08)70525-X"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S3135"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2005.00241.x"},{"key":"e_1_2_7_65_2","unstructured":"McIntyreR PanagidesJ AlphsLet\u00a0al.Efficacy and tolerability of asenapine and olanzapine in acute mania: a double\u2010blind extension study (ARES 7501006).Presented at the 20th ECNP Meeting Vienna 13\u201317 October.2007."},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1112"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00468.x"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.4.442"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01204.x"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00737.x"},{"key":"e_1_2_7_72_2","first-page":"141","volume-title":"Acute Care Psychiatry: Diagnosis and Treatment","author":"Tohen M","year":"1997"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1080\/15622970701805491"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.12.2099"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2004.00411.x"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145706006900"},{"issue":"1","key":"e_1_2_7_77_2","first-page":"35","article-title":"Quetiapine vs. placebo for acute mania associated with bipolar disorder (STAMP1)","volume":"5","author":"Brecher M","year":"2003","journal-title":"Bipolar Disord"},{"issue":"1","key":"e_1_2_7_78_2","first-page":"74","article-title":"Quetiapine monotherapy vs. placebo for acute bipolar mania (STAMP2)","volume":"5","author":"Paulsson B","year":"2003","journal-title":"Bipolar Disord"},{"key":"e_1_2_7_79_2","unstructured":"VietaE KhannaS LyonsB GrossmanF Van KammenD KramerM.Risperidone in the treatment of manic or mixed episodes of bipolar disorder.Poster presented at the American College of Neuropsychopharmacology 41st Annual Meeting Puerto Rico December 8\u201312 2002."},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0405"},{"key":"e_1_2_7_82_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0308"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000194567.63289.97"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.11.1079"},{"key":"e_1_2_7_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.03.019"},{"key":"e_1_2_7_86_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0703"},{"key":"e_1_2_7_87_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0907"},{"key":"e_1_2_7_88_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0505"},{"key":"e_1_2_7_89_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1281"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2009.00710.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2009.00710.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:36:54Z","timestamp":1694561814000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2009.00710.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":88,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1399-5618.2009.00710.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2009.00710.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}